Cargando…
Skin proteomic analysis of immune activation associated with regression of melanoma metastases induced by diphencyprone
Autores principales: | Han, Joseph, Correa da Rosa, Joel, Owji, Shayan, Yassky, Daniel, Luu, Yen, Estrada, Yeriel, Ungar, Jonathan, Ji, Andrew, Krueger, James G., Gulati, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486131/ https://www.ncbi.nlm.nih.gov/pubmed/36147215 http://dx.doi.org/10.1016/j.jdin.2022.08.006 |
Ejemplares similares
-
Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment
por: Han, Joseph, et al.
Publicado: (2022) -
Modulation of Inflammatory Proteins in Serum May Reflect Cutaneous Immune Responses in Cancer Immunotherapy
por: Han, Joseph, et al.
Publicado: (2023) -
Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights
por: Gulati, Nicholas, et al.
Publicado: (2014) -
Impact of vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the atopic dermatitis serum proteome
por: Kim, Madeline, et al.
Publicado: (2023) -
Topical Diphencyprone as an Effective Treatment for Cutaneous Metastatic Melanoma
por: Kim, Young Jin
Publicado: (2012)